Does GAD Have a Unique Role in Triggering IDDM?
- 30 November 2000
- journal article
- review article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 15 (3) , 279-286
- https://doi.org/10.1006/jaut.2000.0443
Abstract
No abstract availableThis publication has 71 references indexed in Scilit:
- Alternative Splicing of GAD67 Results in the Synthesis of a Third Form of Glutamic-acid Decarboxylase in Human Islets and Other Non-neural TissuesJournal of Biological Chemistry, 2000
- Control of Autoimmune DiabetesScience, 2000
- High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylaseJournal of Molecular Biology, 1999
- Antibodies to ICA512/IA-2 in Rodent Models of IDDMJournal of Autoimmunity, 1998
- Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.Journal of Clinical Investigation, 1997
- Combined antibody screening for improved prediction of IDDM — Modern strategiesExperimental and Clinical Endocrinology & Diabetes, 1997
- Susceptibility to type I diabetes: HLA-DQ and DR revisitedImmunology Today, 1996
- Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes.The Journal of Experimental Medicine, 1995
- DNA vaccines: A novel approach to immunizationInternational Journal of Immunopharmacology, 1995
- Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.Journal of Clinical Investigation, 1993